Extraction of pharmaceutically active components from plant materials

a technology of plant materials and active components, which is applied in the direction of solvent extraction, plant/algae/fungi/lichens ingredients, separation processes, etc., to achieve the effect of increasing the selectivity of the extraction process and improving the stability of the final bds

Inactive Publication Date: 2020-10-01
GW PHARMA LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0057]A step of treatment with activated charcoal may be included between step iv) and step v), resulting in improved stability of the final BDS.
[0058]The applicant has further determined that the addi

Problems solved by technology

Furthermore, CO2 extraction is a conservative method of preparat

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Extraction of pharmaceutically active components from plant materials
  • Extraction of pharmaceutically active components from plant materials
  • Extraction of pharmaceutically active components from plant materials

Examples

Experimental program
Comparison scheme
Effect test

example 2-investigation

of the Stabilisation of Botanical Drug Substance (BDS) by Partial Purification Using Activated Charcoal

[0191]Results from stability studies on THC formulations indicate that THC in the form of BDS is unstable even at storage temperatures as low as 5° C. This contrasts with the behaviour of the purified THC (Dronabinol USP) in Marinol soft gel capsules, for which a shelf life of 2 years at cool ambient temperature is accepted. It should also be noted that the shelf life of THC standard solutions in methanol supplied by Sigma-Aldrich is claimed to be 4 years when stored refrigerated and protected from light.

[0192]This apparent discrepancy between the stability of BDS (THC) and purified THC prompted speculation that some component of BDS was destabilising the principal cannabinoid.

[0193]A solution to this problem would be to purify the BDS (THC) to yield high purity, preferably crystalline cannabinoid. However, the additional processing costs incurred on transforming BDS to pure cannab...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the extraction of pharmaceutically active components from plant materials, and more particularly to the preparation of a botanical drug substance (BDS) for incorporation in to a medicament. It also relates to a BDS of given purity, for use in pharmaceutical formulations. In particular it relates to BDS comprising cannabinoids obtained by extraction from cannabis.

Description

RELATED APPLICATIONS[0001]This application is a continuation of U.S. patent application Ser. No. 15 / 467,387, filed Mar. 23, 2017, which is a continuation of U.S. patent application Ser. No. 12 / 049,588, filed Mar. 17, 2008, which is a divisional of U.S. patent application Ser. No. 10 / 218,972, filed Aug. 14, 2002, now U.S. Pat. No. 7,344,736, the entire contents of each of which are incorporated herein by reference in their entireties.FIELD OF THE INVENTION[0002]The present invention relates to the extraction of pharmaceutically active components from plant materials, and more particularly to the preparation of a botanical drug substance (BDS) for incorporation in to a medicament. It also relates to a BDS of given purity, for use in pharmaceutical formulations. In particular it relates to BDS comprising cannabinoids obtained by extraction from cannabis. BACKGROUND OF THE INVENTION[0003]In PCT / GB02 / 00620 the applicant discloses a method of preparing a herbal drug extract (botanical dru...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/185A61K31/352B01D11/02
CPCY02A50/30A61K36/185A61K31/352B01D11/0203
Inventor WHITTLE, BRIAN ANTHONYHILL, COLIN A.FLOCKHART, IAN R.DOWNS, DAVID VICTORGIBSON, PETERWHEATLEY, GARY WILLIAM
Owner GW PHARMA LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products